Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 2
1939 2
1940 1
1947 1
1948 2
1949 3
1950 1
1951 3
1952 1
1953 3
1956 4
1958 3
1959 5
1960 3
1961 1
1962 1
1964 2
1965 6
1966 4
1967 6
1968 5
1969 9
1970 5
1971 12
1972 8
1973 16
1974 23
1975 13
1976 28
1977 23
1978 28
1979 39
1980 37
1981 51
1982 32
1983 46
1984 62
1985 69
1986 68
1987 83
1988 67
1989 81
1990 87
1991 67
1992 79
1993 74
1994 80
1995 75
1996 95
1997 98
1998 109
1999 107
2000 131
2001 118
2002 147
2003 137
2004 166
2005 170
2006 164
2007 185
2008 248
2009 284
2010 267
2011 261
2012 280
2013 282
2014 280
2015 300
2016 353
2017 339
2018 348
2019 387
2020 370
2021 419
2022 422
2023 404
2024 109

Text availability

Article attribute

Article type

Publication date

Search Results

7,496 results

Results by year

Filters applied: . Clear all
Page 1
Cancer statistics, 2023.
Siegel RL, Miller KD, Wagle NS, Jemal A. Siegel RL, et al. Among authors: miller kd. CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763. CA Cancer J Clin. 2023. PMID: 36633525 Free article.
Management of the Difficult Airway.
Miller KA, Goldman MP, Nagler J. Miller KA, et al. Pediatr Emerg Care. 2023 Mar 1;39(3):192-200. doi: 10.1097/PEC.0000000000002916. Epub 2023 Feb 16. Pediatr Emerg Care. 2023. PMID: 36790950 Review.
Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. Among authors: miller k. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
JCO Turns 40.
Miller KD, Friedberg JW. Miller KD, et al. J Clin Oncol. 2023 Jan 1;41(1):1-2. doi: 10.1200/JCO.22.02480. Epub 2022 Nov 18. J Clin Oncol. 2023. PMID: 36399693 No abstract available.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. Ryan CJ, et al. Among authors: miller k. Lancet Oncol. 2015 Feb;16(2):152-60. doi: 10.1016/S1470-2045(14)71205-7. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601341 Clinical Trial.
Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer.
Miller KD, O'Connor S, Pniewski KA, Kannan T, Acosta R, Mirji G, Papp S, Hulse M, Mukha D, Hlavaty SI, Salcido KN, Bertolazzi F, Srikanth YVV, Zhao S, Wellen KE, Shinde RS, Claiborne DT, Kossenkov A, Salvino JM, Schug ZT. Miller KD, et al. Nat Cancer. 2023 Oct;4(10):1491-1507. doi: 10.1038/s43018-023-00636-6. Epub 2023 Sep 18. Nat Cancer. 2023. PMID: 37723305
7,496 results